Stroke
Epidemiology, Evidence and Clinical Practice
-
10% KEDVEZMÉNY?
- A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
- Kiadói listaár GBP 70.00
-
33 442 Ft (31 850 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 10% (cc. 3 344 Ft off)
- Kedvezményes ár 30 098 Ft (28 665 Ft + 5% áfa)
Iratkozzon fel most és részesüljön kedvezőbb árainkból!
Feliratkozom
33 442 Ft
Beszerezhetőség
Megrendelésre a kiadó utánnyomja a könyvet. Rendelhető, de a szokásosnál kicsit lassabban érkezik meg.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadás sorszáma 2
- Kiadó OUP Oxford
- Megjelenés dátuma 1999. augusztus 5.
- ISBN 9780192630759
- Kötéstípus Puhakötés
- Terjedelem356 oldal
- Méret 234x156x19 mm
- Súly 510 g
- Nyelv angol
- Illusztrációk 19 line figures 0
Kategóriák
Rövid leírás:
There has been an explosion of research on stroke in the decade since the publication of the first edition of this book. Increasingly, with vast amounts of data becoming available from clinical trials, clinicians need guidance on the clinical epidemiology, diagnosis, management and prognosis of stroke. This edition is a substantially updated and expanded work and discusses the evidence-base for health care in stroke.
TöbbHosszú leírás:
Almost a decade has passed since the first edition of this book was published and the explosion of new research in stroke is very apparent. Several important themes have coloured medicine during this time: the development of evidence based health care, new optimism for acute drug treatments for stroke, the growth of new information about the human genome, a dramatic increase in the number of stroke clinicians and researchers world-wide, and the establishment of the Cochrane Collaboration. All of these trends are relevant in revising a book of this nature. Clinical epidemiology remains an essential foundation for the practice of evidence-based healthcare. The enthusiasm of the pharmaceutical industry has resulted in a large number of new trials, often too small to detect clinically important differences, and have increased the number of clinicians actively engaged in stroke research. It is even more important that these clinicians should have a good understanding of the design of trials, the rationale for randomisation and blinding, and the importance of selecting the most appropriate outcomes. Surprisingly, little of practical importance has resulted from the decade of exploration of the human genome - the best indication of a person's risk remains their phenotype and not their genotype. The impetus to organise stroke medicine into a defined speciality, with emphasis on acute stroke, is even stronger - but it is essential to bear in mind the importance of interdisciplinary working, the value of primary care, geriatric medicine, psychiatry and rehabilitation in the prevention, treatment rehabilitation and long-term care of stroke patients. The Cochrane Collaboration is currently grappling with a task of enormous size - the compression of tens of thousands of randomised control trials -and other scientific evidence- into systematic reviews of the effects of interventions. Citations to this work are made in the section on management. In this edition, there is an extra opening section entitled Epidemiology which comprises the nuts and bolts of the subject and reviews the purposes of health care for stroke patients. The remaining sections follow the format of the first edition: Diagnosis, Management, and Prognosis. All chapters have been substantially updated. The book retains its focus on epidemiology that is relevant to the clinician and attempts to use examples from stroke to illustrate many aspects of epidemiological thinking. The book aims to stimulate readers to think about their own practice, the nature of scientific evidence and the vast areas of clinical uncertainty that remain the target for research over the coming decades.
TöbbTartalomjegyzék:
Foreword by Charles Warlow
Part 1: EPIDEMIOLOGY
Objectives of stroke care
Risk and risk factors
Time, places and people
Summary
Part 2: DIAGNOSIS
Diagnosis
Clinical Disagreement
Investigation
Severity
Summary
Part 3: MANAGEMENT
Prevention
Acute Management
Rehabilitation
Preventing recurrence
Summary
Part 4: PROGNOSIS
Mortality
Recurrence
Effects of Stroke
Recovery
Summary
References
Index
